SUMMARY
INTRODUCTION
Free radicals are highly reactive molecules/atoms which, due to their unpaired electrons, could impair several vital biomolecules such as lipids, proteins, carbohydrates, and DNA [1] . Any imbalance between the production of these radicals . i r and the natural antioxidant defense systems of the body would lead to a situation called oxidative stress. Heretofore, oxidative stress has been suggested to be implicated in the pathophysiology of around one hundred disorders. Smoking is one of the most well-known contributors of oxidative stress and yet a main risk factor for noncommunicable and chronic diseases. The prevalence of smoking among US adults has been reported to be 20.6% [2] . Based on the findings of a recent study among Tehran residents, some 20.6% of males and 2.9% of females are smokers [3] . Chlorella vulgaris is a green unicellular microalga of fresh water, which has long been used as a popular foodstuff in the Far East countries. C. vulgaris is a natural all-in-one supplement and a rich source of proteins and amino acids, vitamins, minerals, dietary fiber, and unsaturated fatty acids [4, 5] . Owing to its extraordinary high protein content (~50%), C. vulgaris has gained increasing popularity and demand to be used as a superfood and biomass. In addition to its use as a food source, C. vulgaris has also diverse medicinal properties. Previous investigations have unveiled hepatoprotective, immunomodulatory, anti-hypertensive, anti-atherogenic, anti-diabetic, anti-hyperlipidemic, anti-inflammatory, anti-hyperglycemic, antioxidant, anti-tumor, anti-bacterial and anti-viral effects [6] [7] [8] . Such beneficial effects of C. vulgaris are directly related to its diverse content of bioactive micronutrients. It has also been demonstrated that C. vulgaris is a powerful detoxification aid for cadmium, dioxin and many other types of heavy metals, toxins, and pesticides [9, 10] . Finally, this microalga has been affirmed as "generally recognized as safe" (GRAS) by FDA and its consumption has not been reported to be associated with any adverse event in previous clinical trials. Given the high rates of smoking-induced disorders such as cardiovascular disease, lung cancer and chronic obstructive pulmonary disease, and smoking-associated mortality (5 million deaths annually) [11] [12] [13] , there is an apparent need for medications that could counterbalance the biochemical impairments that are induced by smoking. There has been considerable evidence on the reduction of antioxidant status in smoker vs. non-smoker subjects [14] [15] [16] [17] . One way to mitigate the deleterious effects of smoking is to compensate the oxidative damage via consumption of natural antioxidant supplements. Alongside the aforementioned effects, C. vulgaris has promising antioxidant activity [17] [18] [19] . However, most of the findings on the antioxidant effects of Chlorella pertain to animal studies and clinical evidence, especially in cigarette smokers, is minimal. Therefore, the present study aimed to evaluate the effectiveness of supplementation with C. vulgaris on serum antioxidant measures of cigarette smokers.
MATERIALS AND METHODS
This study was performed as a prospective open-label clinical trial. Recruited subjects were apparently healthy smokers (defined as smoking ≥ 20 cigarettes per day) aged 17 -62 years from the personnel of Loghman-Hakim Hospital (Tehran, Iran). Patients who had any chronic disease or history of hypersensitivity to herbal preparations were excluded from the study. A complete explanation about the intervention and its effects was given to all recruited subjects. Then, C. vulgaris extract was administered at a dose of 3600 mg/day (1800 mg b.i.d.) for 6 weeks. The study protocol was approved by the Ethics Committee of the Baqiyatallah University of Medical Sciences and written informed consent was obtained from participants. C. vulgaris extract used in the study was in the form of 300 mg tablets which are commercially available under trade name ALGOMED ® (Bioprodukte Prof. Steinberg Produktions-und Vertriebs GmbH & Co. KG, Klötze, Germany). The tablets contained 98% C. vulgaris powder, 1% separating agent (silicic acid), and 1% plantbased magnesium stearate). The tablets were ~9 mm in diameter and ~300 mg in weight. The ingredients of tablets are summarized in Table 1 (based on the manufacturer's information). Fasted serum samples were collected at baseline as well as at the end of trial. Baseline samples were frozen at -80°C and analyzed in parallel with the post-trial samples. Biochemical factors that were measured in serum samples included vitamin C, vitamin E, Malonedialdehyde (MDA) and glutathione (GSH) concentrations, superoxide dismutase (SOD), glutathione peroxidase (GPx) and catalase (CAT) activities, and total antioxidant status (TAS). GSH measurement was based on the method of Beutler, Duron, and Kelly [20] . In this method, the reaction between GSH and 5,5`-dithiobis-2-nitrobenzoic acid (DTNB) produces a reduced chromogen. The yellowish product has an absorbance at 405 nm which could be measured spectrophotometrically. The activity of SOD was determined using the method described by Ewing and Janero with slight modifications [21] . The method is based on the ability of superoxide radicals -generated by the reaction between NADH and phenazine methosulfate (PMS) -to reduce nitro blue tetrazolium (NBT) to formazan at acidic PH. The production of formazan could be detected spectrophotometrically at 560 nm. SOD is able to react with produced superoxides radicals, thereby preventing NBT conversion to the chromogen product. The change in absorbance over a period of 10 min was monitored at 560 nm with a microplate reader using a kinetic mode. One unit of enzyme activity was defined as the amount of enzyme that gave 50% inhibition of NBT reduction in one minute. Serum catalase activity was measured using a spectrophotometric method described by Aebi [22] . The reaction is based on the disappearance rate of 240 nm in a medium containing 50 mM KPi-buffer (pH 7.0), 0.5 mM EDTA and serum. GPx activity was evaluated using a coupled enzymatic assay [23] . In this assay, glutathione is first oxidized by H 2 O 2 in the presence of GPx. In the second step, oxidized glutathione is reduced by glutathione reductase (GR) in the presence of NADPH. The disappearance rate of NADPH (conversion of NADPH to NADP) was measured as absorbance at 340 nm for 30 s. The reaction mixture contained 50 mM sodium phosphate buffer (pH 7.0), 0.33 mM NADPH, 0.11 M NaN3, 0.12 mM glutathione (GSH), 5 units of GR and serum sample. GPx activity was expressed as micromoles of NADPH oxidized per minute per mg protein.
MDA was measured using the TBARS method [24] . Serum samples were mixed with HCl 0.1N containing 1% phosphoric acid, 10 mM BHT (dissolved in ethanol) and 0.6% TBA. The mixture was then heated at 90°C for an hour cool and then allowed to cool. The pink colored complex was then extracted into n-butanol phase, vortexed and centrifuged at 5000 g for 10 min. The absorbance of supernatant was read at 532 nm. MDA levels are expressed as nanomoles of thiobarbituric acid reactive substances formed per milliliter of plasma. Total antioxidant status (TAS) was measured based on a colorimetric reaction [25] . In this assay, 2,2'-azino-di-[3-ethylbenzethiazoline sulphonate] (ATBS) serves as the reconstituted chromogen and is incubated with sample, a peroxidase (metmyoglobin) and H 2 O 2 to produce a blue-green colored radical cation. The optical density of the radical cation is measured at 600 nm. The initial (A1) and final (A2; after 3 minutes) absorbances of the assay mixture were read prior and 3 minutes after addition of H 2 O 2 to the assay mixture. TAS of each sample was then calculated using the following formula and expressed as mmol/L: TAS = Concentration of Standard × (∆A Blank -∆A Sample)/(∆A Blank -∆A Standard).
Serum vitamin E was measured using an HPLC method and vitamin C using a colorimetric assay, with modifycations of the previously described methods [26] . Values are expressed as mean ± SEM. Vit E -vitamin E, VitC -vitamin C, GPx -glutathione peroxidase, SOD -superoxide dismutase, CATcatalase, GSH -glutathione, TAC -total antioxidant capacity, MDA -malonedialdehyde.
RESULTS
Out of the 40 individuals who initially entered the trial, 2 were dropped due to gastrointestinal side effects while 38 (male/female: 31/7) completed the trial and were included in the final analyses. There was no significant difference between males and females regarding age, duration of smoking habit, physical activity level and daily consumption of fruits and vegetables. Demographic characteristics of the study population are summarized in Table 2 .
Effect of C. vulgaris supplementation on oxidative stress biomarkers
In the overall study population, supplementation with C. vulgaris was associated with significant elevations in serum levels of GSH, SOD, GPx, CAT, vitamin E, vitamin C, and TAS (p < 0.001) while a decrease in MDA (p = 0.002) ( Table 3) .
In males, all assessed antioxidant measures were significantly increased by the end of trial (p < 0.001). There was a similar trend for females (p = 0.032 for vitamin C, p = 0.006 for SOD; p = 0.005 for TAS, and p < 0.001 for GPx, CAT, and GSH) except for serum Vit E concentrations which remained unchanged compared to baseline (p > 0.05). Serum MDA levels decreased by the end of trial in both males (p < 0.001) and females (p = 0.007) subgroups (Table 4) . As for the magnitude of changes in antioxidant measures and MDA, no significant difference was observed between males and females (p > 0.05). The only exception was the amount of Vit E elevation, which was significantly greater in males compared to females (p = 0.014) ( Table 5) .
Bivariate analyses
Bivariate correlations between serum antioxidant indices and MDA levels were evaluated at baseline as well as at the end of trial. . i r neither in the overall population nor in the male subgroup. In females, Vit E levels were found to be correlated with CAT (p = 0.029) and MDA (p = 0.067).When the association between changes in the evaluated parameters was assessed, no significant correlation was observed, neither in the overall population nor in each individual gender (p > 0.05).
DISCUSSION
The purpose of the current study was to determine the antioxidant potential of C. vulgaris in smokers. The results clearly supported the relevance of C. vulgaris in the enhancement of serum antioxidant status and reducing lipid peroxidation. C. vulgaris contains a broad spectrum of micro-and macronutrients including essential antioxidant vitamins, trace elements, ω-3 and ω-6 fatty acids and miscellaneous antioxidants such as lutein, zeaxanthin, chlorophyll, and lycopene [4,5; Table 1 ]. Due to this rich composition, C. vulgaris is supposed to function as a powerful antioxidant supplement. Analysis of serum oxidative stress biomarkers indicated a raised level of MDA along with a depleted status of SOD, GPx, vitamins E and C, CAT, and GSH compared to values previously reported for healthy individuals [27] [28] [29] [30] .
Our findings in the present study confirmed this notion as Chlorella boosted serum levels of all seven antioxidant measures that were measured in the serum of smokers. In addition, C. vulgaris supplementation reduced serum levels of MDA, which is a well-known lipid peroxidation product and widely used biomarker of oxidative stress. These beneficial effects of C. vulgaris in smoker subjects are of special importance as these subjects are subjected to a heightened burden of oxidative stress [14] [15] [16] [17] and are therefore more susceptible to developing subsequent vascular and respiratory disorders. This elevated level of oxidative stress in smokers could be attributed to two factors. First, cigarette smoke contains around 3500 chemicals of which the majority is toxic, carcinogenic, and mutagenic [31] . Therefore, cigarette smoke is a rich source of free radicals and may directly induce oxidative stress. On the other hand, there has been epidemiologic evidence indicating that smokers consume fewer amounts of phytonutrient-rich foods such as fruits and vegetables in their daily diet [32, 33] . Our findings corroborate those of previous studies. In a recent investigation on the antioxidant capacities of 12 strains of microalga, C. vulgaris showed promising activity in FRAP and DPPH-HPLC assays and was among the most active tested species [18] . Shibata and colleagues reported the reduction of serum peroxides in streptozocin-induced diabetes following 11-week dietary feeding with Chlorella powder [34] . In another study on mice fed with an atherogenic diet, addition of 5% Chlorella was associated with significant reductions in thiobarbituric acid reactive substances and superoxide anion generation as well as enhancement of hepatic SOD and CAT activities [19] . In a survey by Blas-Valdivia and colleagues, C. vulgaris administration was shown to protect against HgCl 2 -induced oxidative stress and cellular damage in kidney by decreasing lipid peroxidation and reactive oxygen species and increasing glutathione content [35] . Yun et al. showed that 4-week supplementation with C. vulgaris exerts protective antioxidant effects against lead-induced oxidative stress, manifested by increased SOD, GPx and glutathione reductase activities, elevated glutathione content, and decreased MDA levels [36] . C. vulgaris extract has also been shown to protect against carbon tetrachloride-induced acute hepatic injury in mice. Inhibition of lipid peroxidation together with boosting hepatic glutathione content and activities of SOD, GPx, and glutathione-S-transferase enzymes have been reported as key mechanisms for this hepatoprotection [37] . There has also been further evidence confirming the antioxidant potential of C. vulgaris in different oxidative systems [7, 34, [38] [39] [40] . Heretofore, C. vulgaris has been the subject of a number of trials ( Table 6 ). The robust trial by Lee et al. is the study most related to the present work. In the referred study, the effect of 6-week supplementation with C. vulgaris (6.3 g/day) was investigated on antioxidant status of Korean male smokers. Based on their results, the authors demonstrated that C. vulgaris increased plasma Vit C (by 44.4%), α-tocopherol (by 15.7%), and erythrocyte catalase and superoxide dismutase activities [41] . The results of the present study further confirmed these findings and provided additional evidence with respect to the antioxidant efficacy of a much lower C. vulgaris dose i.d. 1800 mg/day. In addition, the percentages of Vit C and Vit E elevations in the present (57.3% and 69.0% for Vit C and Vit E, respectively) study were much higher than those reported by Lee et al. (44.4% and 15.7%) . Overall, C. vulgaris supplementation was found to be safe and there was no report of serious adverse events following Chlorella consumption. This is consistent with the findings of our previous clinical investigations, in which there was no negative effect of C. vulgaris extract on circulating biomarkers of hepatic function (aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase and bilirubin), renal function (creatinine and blood urea nitrogen) as well as albumin, uric acid, and glucose levels [42] [43] [44] . In summary, the findings of the present trial favored the antioxidant impact of 6-week supplementation with C. vulgaris extract in chronic cigarette smokers. The most important limitation of the current study lies in its lack of blindness, placebo-controlling, and dietary intake assessment together with the relatively small number of recruited subjects. Hence, a large-scale double blind placebo-controlled trial with full nutrition intake assessment would have eliminated possible bias and reflect the effectiveness of C. vulgaris in a more precise manner. Another limitation is the lack of precise monitoring
. i r of daily smoking. Such information allows the evaluation of the association between the degree of smoking and severity of alterations in serum oxidative stress biomarkers. In addition, future prospective investigations are warranted to clarify whether these antioxidant effects of C. vulgaris in smokers are translated into a lower frequency of cardiovascular and pulmonary outcomes and decreased mortality rates. Finally, given the close association between oxidative stress and inflammation, it would be interesting to explore if the observed antioxidant properties of C. vulgaris are associated with a significantly decreased burden of inflammation and alterations in the circulating levels of inflammatory biomarkers. 
